The ANP story is getting more compelling every day. The last time Pfizer failed with their gene therapy trials we saw a major rerate in the ANP share price. Billions of dollars invested in GT and now the future is looking bleak and the FDA being risk averse will be extremely cautious of approving any future GT research proposals. In steps ANP with a positive data for inflammation and fibrosis. We can no longer be ignored. I expect Insto's to be all over this in the next couple weeks.... so exciting, GLTA holders..
The ANP story is getting more compelling every day. The last...
-
- There are more pages in this discussion • 712 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
